Research workbench
AlphaFold monomer V2.0 prediction for ribosomal protein L11 methyltransferase (A2C717)
Analyse AlphaFold monomer V2.0 prediction for ribosomal protein L11 methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- Accession
- A2C717
- Type
- protein
- Length
- 301 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x59831851785564a18a1683eC0D58dc237FF9e3E0
- Molecule
- Ribosomal protein L11 methyltransferase
- UniProt
- A2C717
- Pockets
- 1 · best druggability 0.69
Structure
1 distinct chain · 37% helix, 32% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Ribosomal protein L11 methyltransferase | protein | 301 | 37% helix, 32% strand | A2C717 |
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 449 | 0.69 | 0.80 | 46 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A2C717
- Elsewhere: UniProt A2C717 · AlphaFold DB A2C717
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.